CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
7 Tesla Magnetic Resonance Imaging +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04539574
NCT04539574N/ACompleted
CompareCT.gov

Validation of a Multi-Parametric Ultra-High Field MRI Protocol for Central Nervous System Malignancy

M.D. Anderson Cancer Center·interventional·Posted Sep 7, 2020·Updated Jan 8, 2025

In Brief

A clinical study evaluating 7 Tesla Magnetic Resonance Imaging and Questionnaire Administration for Central Nervous System Neoplasm and 3 related conditions. Completed, enrolled 50 participants across 1 site.

Detailed Summary

This trial investigates how well 7T MRI scan works in imaging central nervous system tumors. Diagnostic procedures, such as 7T MRI, may help find and diagnose central nervous system tumors and help measure a patient's response to earlier treatment. The goal of this trial is to learn if a new MRI system can provide better quality images than a standard MRI.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCentral Nervous System Neoplasm, Glioma, Metastatic Malignant Neoplasm in the Central Nervous System, Metastatic Malignant Solid Neoplasm
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedSep 7, 2020
Enrollment StartSep 4, 2020
Primary CompletionApr 26, 2024
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 5.8 years ago

Interventions

7 Tesla Magnetic Resonance Imagingprocedure

Undergo 7T MRI

Questionnaire Administrationother

Ancillary studies